Please wait...

Maximize the utility of
imaging biomarkers
to the benefit of
patients with arthritis.
Learn more about the project  

AutoPiX is a major international project focused on improving healthcare for people with rheumatic and musculoskeletal diseases (RMDs).

The AutoPiX project brings together pharmaceutical and medical technology partners with leading academic institutions to enhance the use of imaging biomarkers for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), collectively known as systemic arthritides.

It aims to develop advanced imaging tools and artificial intelligence (AI) models to better diagnose, monitor, and treat these conditions. These tools will make use of imaging biomarkers—like X-rays, ultrasounds, and MRIs—to provide more precise and personalised care.

AutoPiX is a major international project focused on improving healthcare for people with rheumatic and musculoskeletal diseases (RMDs).

The AutoPiX project brings together pharmaceutical and medical technology partners with leading academic institutions to enhance the use of imaging biomarkers for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), collectively known as systemic arthritides.

It aims to develop advanced imaging tools and artificial intelligence (AI) models to better diagnose, monitor, and treat these conditions. These tools will make use of imaging biomarkers—like X-rays, ultrasounds, and MRIs—to provide more precise and personalised care.

Learn more about the project  
Partners / Singularity Biomed

Singularity Biomed

Singularity Biomed is a MedTech startup focused on developing innovative solutions in rheumatology. Established in Barcelona in 2019, the company specialises in Software as a Medical Device (SaMD) powered by machine learning to assist healthcare professionals in diagnosing and monitoring inflammatory joint diseases such as rheumatoid arthritis. The company aims to improve patient outcomes, enhance quality of life, and optimise healthcare resource utilisation.

What is the role of Singularity Biomed in Autopix

Singularity Biomed is contributing to Work Package 3 (WP3) of AutoPIX by validating its machine learning model for detecting hand arthritis through thermal imaging across international patient cohorts. The institution will also assess the model’s usability as a point-of-care screening tool throughout different stages of the patient journey.

Q&A

In what part of the patient journey will your institution most likely contribute?

Singularity Biomed primarily contributes to early diagnosis and disease monitoring of rheumatoid arthritis (WP3). Our technology provides fast, objective, and cost-effective detection of joint inflammation at the point of care, facilitating timely intervention.

What long-term impacts do you envision of your contribution?

By integrating our technology into clinical workflows, we aim to enable earlier detection of inflammation and timely treatment adjustments. In the long term, this could enhance patient quality of life, reduce healthcare costs, and optimise resource allocation. Our work also supports a shift towards personalised, data-driven care in rheumatology.

Why is it so important?

Rheumatoid arthritis affects millions worldwide, causing pain, disability, and a significant economic burden. Our technology empowers clinicians with a fast, objective, and accessible tool, improving decision-making and ultimately leading to better patient outcomes.

Team picture of Singularity Biomed

Contact

Isabel Morales Ivorra
MD, PhD – Co-Founder & CSO
Manuel Alejandro Marín López
MSc, PhD – Co-Founder & CEO